Use of Hepatitis C Virus (HCV) Immunoglobulin G Antibody Avidity as a Biomarker to Estimate the Population-Level Incidence of HCV Infection

Background. Sensitive methods are needed to estimate the population-level incidence of hepatitis C virus (HCV) infection. Methods. We developed an HCV immunoglobulin G (IgG) antibody avidity assay by modifying the Ortho 3.0 HCV enzyme-linked immunoassay and tested 997 serum or plasma samples from 56...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Infect Dis
Autores principales: Patel, Eshan U., Cox, Andrea L., Mehta, Shruti H., Boon, Denali, Mullis, Caroline E., Astemborski, Jacquie, Osburn, William O., Quinn, Jeffrey, Redd, Andrew D., Kirk, Gregory D., Thomas, David L., Quinn, Thomas C., Laeyendecker, Oliver
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2016
Materias:
Major Articles and Brief Reports
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4936640/
https://ncbi.nlm.nih.gov/pubmed/26768250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiw005
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares